Next Article in Journal
Combining Hexanoic Acid Plant Priming with Bacillus thuringiensis Insecticidal Activity against Colorado Potato Beetle
Next Article in Special Issue
Serum Metallothioneins in Childhood Tumours — A Potential Prognostic Marker
Previous Article in Journal
Eviprostat Activates cAMP Signaling Pathway and Suppresses Bladder Smooth Muscle Cell Proliferation
Previous Article in Special Issue
Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2013, 14(6), 12123-12137; doi:10.3390/ijms140612123

Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer

Department of Obstetrics and Gynecology, School of Medicine, Keio University, Shinanomachi 35 Shinjuku-ku, Tokyo 160-8582, Japan
*
Author to whom correspondence should be addressed.
Received: 27 February 2013 / Revised: 15 May 2013 / Accepted: 20 May 2013 / Published: 6 June 2013
(This article belongs to the Special Issue Advances in Cancer Diagnosis)
View Full-Text   |   Download PDF [598 KB, uploaded 19 June 2014]   |  

Abstract

The recent increase in the frequency of endometrial cancer has emphasized the need for accurate diagnosis and improved treatment. The current diagnosis is still based on conventional pathological indicators, such as clinical stage, tumor differentiation, invasion depth and vascular invasion. However, the genetic mechanisms underlying endometrial cancer have gradually been determined, due to developments in molecular biology, leading to the possibility of new methods of diagnosis and treatment planning. New candidate biomarkers for endometrial cancer include those for molecular epigenetic mutations, such as microRNAs. These biomarkers may permit earlier detection of endometrial cancer and prediction of outcomes and are likely to contribute to future personalized therapy for endometrial cancer. View Full-Text
Keywords: endometrial cancer; microsatellite instability; MSH6; DNA hypermethylation; CHFR; microRNA; Lynch syndrome; PTEN; K-ras; CA125 endometrial cancer; microsatellite instability; MSH6; DNA hypermethylation; CHFR; microRNA; Lynch syndrome; PTEN; K-ras; CA125
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Banno, K.; Nogami, Y.; Kisu, I.; Yanokura, M.; Umene, K.; Masuda, K.; Kobayashi, Y.; Yamagami, W.; Susumu, N.; Aoki, D. Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer. Int. J. Mol. Sci. 2013, 14, 12123-12137.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top